Veeva Systems says UCB is unifying its global pharmacovigilance and safety operations using the Veeva Safety Suite. The announcement, distributed by Veeva, states that the move is intended to create an end-to-end safety foundation across UCB’s safety processes. According to the company, the unified approach is designed to support faster processing of pharmacovigilance cases and to enable greater automation of safety workflows.
The release positions the integration as a way to improve operational efficiency while scaling UCB’s global safety operations. The information provided is based on Veeva’s public statement and does not include additional details such as timelines, regions covered, implementation scope, or measurable performance outcomes. No other sources are included in the provided materials, so the summary reflects only the claims made in the announcement. The duplicated entries with different datelines appear to refer to the same announcement on June 9, 2026.
